Kevin Chih-Yang Huang (Chih-Yang Huang)

ResearcherID ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 30

Top Venues

Cell death & disease

Journal of cellular physiology

Journal for immunotherapy of cancer

Cancer immunology, immunotherapy : CII

China Medical University

National Chung Hsing University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

China Medical University Aug 01 2020

Taiwan

Assistant Professor :: Department of Biomedical Image and Radiologic Science

China Medical University Hospital Feb 01 2019

Taiwan

Associate Research Fellow :: Translation Research Core

China Medical University Hospital Aug 01 2015 - Jan 31 2019

Taiwan

Assistant Research Fellow :: Translation Research Core

China Medical University Jun 15 2013 - Jul 31 2015

Taiwan

Postdoctoral researcher :: Institute of Basic Medical Science

Education History

National Chung Hsing University Sep 01 2007 - May 30 2012

Taiwan

PHD :: Institute of Microbiology and Public Health

National Chung Hsing University Sep 01 2005 - Jul 31 2007

Taiwan

MSC :: Institute of Biomedical Science

National Chung Hsing University Sep 01 2001 - Jun 30 2005

Taiwan

BSC :: Department of Life Science

Publications

Kevin Chih-Yang Huang, Shu-Fen Chiang, Pei-Chun Lin, Wei-Ze Hong, Pei-Chen Yang, Hui-Ping Chang, Shin-Lei Peng, Tsung-Wei Chen, Tao-Wei Ke, Ji-An Liang, William Tzu-Liang Chen, Kun-San Clifford Chao
TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer. Cell death & disease 15 (1) (2024)
Kevin Chih-Yang Huang, William Tzu-Liang Chen, Jia-Yi Chen, Chien-Yueh Lee, Chia-Hsin Wu, Chia-Ying Lai, Pei-Chen Yang, Ji-An Liang, An-Cheng Shiau, Kun-San Clifford Chao, Tao-Wei Ke
Neoantigen-augmented iPSC cancer vaccine combined with radiotherapy promotes antitumor immunity in poorly immunogenic cancers. NPJ vaccines 9 (1) (2024)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Pei-Chun Lin, Wei-Ze Hong, Pei-Chen Yang, Hui-Ping Chang, Shin-Lei Peng, Tsung-Wei Chen, Tao-Wei Ke, Ji-An Liang, William Tzu-Liang Chen, Kun-San Clifford Chao
TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer. Cell death & disease 15 (1) (2024)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Hsin-Yu Chang, Wei-Ze Hong, Jhen-Yu Chen, Pei-Chih Lee, Ji-An Liang, Tao-Wei Ke, Shin-Lei Peng, An-Cheng Shiau, Tsung-Wei Chen, Pei-Chen Yang, William Tzu-Liang Chen, Kun-San Clifford Chao
Colorectal cancer-specific IFNβ delivery overcomes dysfunctional dsRNA-mediated type I interferon signaling to increase the abscopal effect of radiotherapy. Journal for immunotherapy of cancer 12 (5) (2024)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Hsin-Yu Chang, Wei-Ze Hong, Jhen-Yu Chen, Pei-Chih Lee, Ji-An Liang, Tao-Wei Ke, Shin-Lei Peng, An-Cheng Shiau, Tsung-Wei Chen, Pei-Chen Yang, William Tzu-Liang Chen, Kun-San Clifford Chao
Colorectal cancer-specific IFNβ delivery overcomes dysfunctional dsRNA-mediated type I interferon signaling to increase the abscopal effect of radiotherapy. Journal for immunotherapy of cancer 12 (5) (2024)
Kevin Chih-Yang Huang, William Tzu-Liang Chen, Jia-Yi Chen, Chien-Yueh Lee, Chia-Hsin Wu, Chia-Ying Lai, Pei-Chen Yang, Ji-An Liang, An-Cheng Shiau, Kun-San Clifford Chao, Tao-Wei Ke
Neoantigen-augmented iPSC cancer vaccine combined with radiotherapy promotes antitumor immunity in poorly immunogenic cancers. NPJ vaccines 9 (1) (2024)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Pei-Chun Lin, Wei-Ze Hong, Pei-Chen Yang, Hui-Ping Chang, Shin-Lei Peng, Tsung-Wei Chen, Tao-Wei Ke, Ji-An Liang, William Tzu-Liang Chen, Kun-San Clifford Chao
TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer. Cell death & disease 15 (1) (2024)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Pei-Chun Lin, Wei-Ze Hong, Pei-Chen Yang, Hui-Ping Chang, Shin-Lei Peng, Tsung-Wei Chen, Tao-Wei Ke, Ji-An Liang, William Tzu-Liang Chen, Kun-San Clifford Chao
TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer. Cell death & disease 15 (1) (2024)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Hsin-Yu Chang, Wei-Ze Hong, Jhen-Yu Chen, Pei-Chih Lee, Ji-An Liang, Tao-Wei Ke, Shin-Lei Peng, An-Cheng Shiau, Tsung-Wei Chen, Pei-Chen Yang, William Tzu-Liang Chen, Kun-San Clifford Chao
Colorectal cancer-specific IFNβ delivery overcomes dysfunctional dsRNA-mediated type I interferon signaling to increase the abscopal effect of radiotherapy. Journal for immunotherapy of cancer 12 (5) (2024)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Hsin-Yu Chang, Wei-Ze Hong, Jhen-Yu Chen, Pei-Chih Lee, Ji-An Liang, Tao-Wei Ke, Shin-Lei Peng, An-Cheng Shiau, Tsung-Wei Chen, Pei-Chen Yang, William Tzu-Liang Chen, Kun-San Clifford Chao
Colorectal cancer-specific IFNβ delivery overcomes dysfunctional dsRNA-mediated type I interferon signaling to increase the abscopal effect of radiotherapy. Journal for immunotherapy of cancer 12 (5) (2024)
Kevin Chih-Yang Huang, Tao-Wei Ke, Jia-Yi Chen, Wei-Ze Hong, Shu-Fen Chiang, Chia-Ying Lai, Tsung-Wei Chen, Pei-Chen Yang, Liang-Chi Chen, Ji-An Liang, William Tzu-Liang Chen, Kun-San Clifford Chao
Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer. Scientific reports 13 (1) (2023)
Yun-Shan Lin, Shu-Fen Chiang, Chia-Yi Chen, Wei-Ze Hong, Tsung-Wei Chen, William Tzu-Liang Chen, Tao-Wei Ke, Pei-Chen Yang, Ji-An Liang, An-Cheng Shiau, Kun-San Clifford Chao, Kevin Chih-Yang Huang
Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturation. Cancer immunology, immunotherapy : CII (2023)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Hsin-Yu Chang, William Tzu-Liang Chen, Pei-Chen Yang, Tsung-Wei Chen, Ji-An Liang, An-Cheng Shiau, Tao-Wei Ke, Kun-San Clifford Chao
Engineered sTRAIL-armed MSCs overcome STING deficiency to enhance the therapeutic efficacy of radiotherapy for immune checkpoint blockade. Cell death & disease 13 (7) (2022)
Kevin Chih-Yang Huang, Chia-Ying Lai, Wei-Ze Hong, Hsin-Yu Chang, Pei-Chun Lin, Shu-Fen Chiang, Tao-Wei Ke, Ji-An Liang, An-Cheng Shiau, Pei-Chen Yang, William Tzu-Liang Chen, Kun-San Clifford Chao
A Novel Engineered AAV-based Neoantigen Vaccine in Combination with Radiotherapy Eradicates Tumors. Cancer immunology research (2022)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Tao-Wei Ke, Tsung-Wei Chen, Ching-Han Hu, Pei-Chen Yang, Hsin-Yu Chang, Ji-An Liang, William Tzu-Liang Chen, Kun-San Clifford Chao
DNMT1 constrains IFNβ-mediated anti-tumor immunity and PD-L1 expression to reduce the efficacy of radiotherapy and immunotherapy. Oncoimmunology 10 (1) (2021)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Pei-Chen Yang, Tao-Wei Ke, Tsung-Wei Chen, Chen-Yu Lin, Hsin-Yu Chang, William Tzu-Liang Chen, Kun-San Clifford Chao
ATAD3A stabilizes GRP78 to suppress ER stress for acquired chemoresistance in colorectal cancer. Journal of cellular physiology 236 (9) (2021)
Yu-Ting Yen, May Chien, Pei-Yi Wu, Chi-Chang Ho, Chun-Te Ho, Kevin Chih-Yang Huang, Shu-Fen Chiang, K S Clifford Chao, William Tzu-Liang Chen, Shih-Chieh Hung
Protein phosphatase 2A inactivation induces microsatellite instability, neoantigen production and immune response. Nature communications 12 (1) (2021)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Tao-Wei Ke, Tsung-Wei Chen, Ching-Han Hu, Pei-Chen Yang, Hsin-Yu Chang, Ji-An Liang, William Tzu-Liang Chen, Kun-San Clifford Chao
DNMT1 constrains IFNβ-mediated anti-tumor immunity and PD-L1 expression to reduce the efficacy of radiotherapy and immunotherapy. Oncoimmunology 10 (1) (2021)
Shu-Fen Chiang, Kevin Chih-Yang Huang, William Tzu-Liang Chen, Tsung-Wei Chen, Tao-Wei Ke, Kun-San Clifford Chao
An independent predictor of poor prognosis in locally advanced rectal cancer: rs867228 in formyl peptide receptor 1 (FPR1). Oncoimmunology 10 (1) (2021)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Pei-Chen Yang, Tao-Wei Ke, Tsung-Wei Chen, Ching-Han Hu, Yi-Wen Huang, Hsin-Yu Chang, William Tzu-Liang Chen, Kun-San Clifford Chao
Immunogenic Cell Death by the Novel Topoisomerase I Inhibitor TLC388 Enhances the Therapeutic Efficacy of Radiotherapy. Cancers 13 (6) (2021)
Shu-Fen Chiang, Kevin Chih-Yang Huang, William Tzu-Liang Chen, Tsung-Wei Chen, Tao-Wei Ke, Kun-San Clifford Chao
Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer. Cancer immunology, immunotherapy : CII 70 (10) (2021)
Kevin Chih-Yang Huang, Shu-Fen Chiang, William Tzu-Liang Chen, Tsung-Wei Chen, Ching-Han Hu, Pei-Chen Yang, Tao-Wei Ke, K S Clifford Chao
Decitabine Augments Chemotherapy-Induced PD-L1 Upregulation for PD-L1 Blockade in Colorectal Cancer. Cancers 12 (2) (2020)
Kevin Chih-Yang Huang, Shu-Fen Chiang, Tsung-Wei Chen, William Tzu-Liang Chen, Pei-Chen Yang, Tao-Wei Ke, Kun-San Clifford Chao
Prognostic relevance of programmed cell death 1 ligand 2 (PDCD1LG2/PD-L2) in patients with advanced stage colon carcinoma treated with chemotherapy. Scientific reports 10 (1) (2020)
Tsung-Wei Chen, Kevin Chih-Yang Huang, Shu-Fen Chiang, William Tzu-Liang Chen, Tao-Wei Ke, K S Clifford Chao
Prognostic relevance of programmed cell death-ligand 1 expression and CD8+ TILs in rectal cancer patients before and after neoadjuvant chemoradiotherapy. Journal of cancer research and clinical oncology 145 (4) (2019)
Chung-Hao Chen, Jing-Wei Lin, Kevin Chih-Yang Huang, Yu-Lan Yeh, Chia-Yao Shen, Badrealam Farheen Khan, Tsung-Jung Ho, V Vijaya Padma, Wei-Wen Kuo, Chih-Yang Huang
The combined inhibition of the CaMKIIδ and calcineurin signaling cascade attenuates IGF-IIR-induced cardiac hypertrophy. Journal of cellular physiology 235 (4) (2019)
Kevin Chih-Yang Huang, Shu-Fen Chiang, William Tzu-Liang Chen, Tao-Wei Ke, Tsung-Wei Chen, Ying-Shu You, Chen-Yu Lin, K S Clifford Chao, Chih-Yang Huang
HMGB1 promotes ERK-mediated mitochondrial Drp1 phosphorylation for chemoresistance through RAGE in colorectal cancer. Cell death & disease 9 (10) (2018)
Kevin Chih-Yang Huang, Wei-Wen Kuo, Tsung-Jung Ho, Shu-Fen Chiang, Pei-Ying Pai, Jing-Ying Lin, Ding-Yu Lin, Chia-Hua Kuo, Chih-Yang Huang
Rab9-dependent autophagy is required for the IGF-IIR triggering mitophagy to eliminate damaged mitochondria. Journal of cellular physiology 233 (9) (2018)
Shu-Fen Chiang, Kevin Chih-Yang Huang, Tao-Wei Ke, Tsung-Wei Chen, Yu-Ching Lan, Ying-Shu You, William Tzu-Liang Chen, Kun-San Clifford Chao
Upregulation of tumor PD-L1 by neoadjuvant chemoradiotherapy (neoCRT) confers improved survival in patients with lymph node metastasis of locally advanced rectal cancers. Cancer immunology, immunotherapy : CII 68 (2) (2018)
Kevin Chih-Yang Huang, Fa-Lun Lee, Shu-Fen Peng, Kuan-Ho Lin, Ray-Jade Chen, Tsung-Jung Ho, Fu-Jen Tsai, Vijaya V Padma, Wei-Wen Kuo, Chih-Yang Huang
HSF1 phosphorylation by ERK/GSK3 suppresses RNF126 to sustain IGF-IIR expression for hypertension-induced cardiomyocyte hypertrophy. Journal of cellular physiology 233 (2) (2017)
Kevin Chih-Yang Huang, Jia-Yi Chen, Chia-Hua Kuo, Pei-Ying Pai, Tsung-Jung Ho, Tung-Sheng Chen, Fu-Jen Tsai, Vijaya V Padma, Wei-Wen Kuo, Chih-Yang Huang
Mitochondrial ROS-induced ERK1/2 activation and HSF2-mediated AT1 R upregulation are required for doxorubicin-induced cardiotoxicity. Journal of cellular physiology 233 (1) (2017)

Kevin Chih-Yang Huang.css-eqlu8i{font-size:small;padding-left:4px;} (Chih-Yang Huang)

Publication Activity (10 Years)

Top Topics

Top Venues

Kevin Chih-Yang Huang (Chih-Yang Huang)